Sustained expression of GRAIL during hematopoiesis results in dysregulated differentiation

Acta Haematologica

Volumn 122, Issue 4, 2009, Pages 230-237

  MacKenzie, Debra A ^a   Seroogy, Christine M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Hematopoiesis; Hematopoietic progenitor cells; Megakaryocytes thrombocytopenia; Stem cell biology

Indexed keywords

METHYLCELLULOSE; UBIQUITIN PROTEIN LIGASE E3;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CELL COUNT; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CONTROLLED STUDY; ERYTHROPOIESIS; GRANULOCYTE; HEMATOPOIESIS; IN VITRO STUDY; IN VIVO STUDY; MEGAKARYOPOIESIS; MONOCYTE; MOUSE; MULTIPOTENT STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROVIRUS; STABLE EXPRESSION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TRANSCRIPTION REGULATION; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CELL DIFFERENTIATION; ERYTHROPOIESIS; GENE EXPRESSION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; MICE; MICE, INBRED BALB C; MULTIPOTENT STEM CELLS; RADIATION CHIMERA; RECOMBINANT PROTEINS; RNA, MESSENGER; THROMBOPOIESIS; TRANSDUCTION, GENETIC; UBIQUITIN-PROTEIN LIGASES;

EID: 70350543696     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000253591     Document Type: Article

References (22)

1. Cantor AB, Orkin SH: Hematopoietic development: a balancing act. Curr Opin Genet Dev 2001; 11: 513-519.
2. Joazeiro CA, Weissman AM: Ring finger proteins: mediators of ubiquitin ligase activity. Cell 2000; 102: 549-552.
3. Soares L, Seroogy C, Skrenta H, Anandasabapathy N, Lovelace P, Chung CD, Engleman E, Fathman CG: Two isoforms of otubain 1 regulate T cell anergy via grail. Nat Immunol 2004; 5: 45-54.
4. Seroogy CM, Soares L, Ranheim EA, Su L, Holness C, Bloom D, Fathman CG: The gene related to anergy in lymphocytes, an E3 ubiquitin ligase, is necessary for anergy induction in CD4 t cells. J Immunol 2004; 173: 79-85.
5. Guais A, Siegrist S, Solhonne B, Jouault H, Guellaen G, Bulle F: H-goliath, paralog of GRAIL, is a new E3 ligase protein, expressed in human leukocytes. Gene 2006; 374: 112-120.
6. Van Parijs L, Refaeli Y, Abbas AK, Baltimore D: Autoimmunity as a consequence of retrovirus- mediated expression of C-FLIP in lymphocytes. Immunity 1999; 11: 763-770.
7. Anandasabapathy N, Ford G, Bloom D, Holness C, Seroogy C, Skrenta H, Hollenhurst M, Fathman CG, Soares L: Grail: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells. Immunity 2003; 18: 1-20.
8. Costa GL, Benson JM, Seroogy CM, Achacoso P, Fathman CG, Nolan GP: Targeting rare populations of murine antigen-specific T lymphocytes by retroviral transduction for potential application in gene therapy for autoimmune disease. J Immunol 2000; 164: 3581-3590.
9. Mackenzie DA, Schartner J, Lin J, Timmel A, Jennens-Clough M, Fathman CG, Seroogy CM: GRAIL is upregulated in CD4+ CD25+ T regulatory cells and is sufficient for conversion of T cells to a regulatory phenotype. J Biol Chem 2007; 282: 9696-9702.
10. Akashi K, Traver D, Miyamoto T, Weissman IL: A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 2000; 404: 193-197.
11. Slayton WB, Georgelas A, Pierce LJ, Elenitoba- Johnson KS, Perry SS, Marx M, Spangrude GJ: The spleen is a major site of megakaryopoiesis following transplantation of murine hematopoietic stem cells. Blood 2002; 100: 3975-3982.
12. Lineberry NB, Su LL, Lin JT, Coffey GP, Seroogy CM, Fathman CG: Cutting edge: the transmembrane E3 ligase GRAIL ubiquitinates the costimulatory molecule CD40 ligand during the induction of T cell anergy. J Immunol 2008; 181: 1622-1626.
13. Su L, Lineberry N, Huh Y, Soares L, Fathman CG: A novel E3 ubiquitin ligase substrate screen identifies rho guanine dissociation inhibitor as a substrate of gene related to anergy in lymphocytes. J Immunol 2006; 177: 7559-7566.
14. Juris SJ, Shah K, Shokat K, Dixon JE, Vacratsis PO: Identification of otubain 1 as a novel substrate for the yersinia protein kinase using chemical genetics and mass spectrometry. FEBS Lett 2006; 580: 179-183.
15. Orkin SH: Diversification of haematopoietic stem cells to specific lineages. Nat Rev Genet 2000; 1: 57-64.
16. Kondo M, Scherer DC, Miyamoto T, King AG, Akashi K, Sugamura K, Weissman IL: Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature 2000; 407: 383-386.
17. Iwasaki-Arai J, Iwasaki H, Miyamoto T, Watanabe S, Akashi K: Enforced granulocyte/ macrophage colony-stimulating factor signals do not support lymphopoiesis, but instruct lymphoid to myelomonocytic lineage conversion. J Exp Med 2003; 197: 1311-1322.
18. Zhang Y, Morrone G, Zhang J, Chen X, Lu X, Ma L, Moore M, Zhou P: CUL-4A stimulates ubiquitylation and degradation of the HOXA9 homeodomain protein. Embo J 2003; 22: 6057-6067.
19. Liu LQ, Ilaria R Jr, Kingsley PD, Iwama A, van Etten RA, Palis J, Zhang DE: A novel ubiquitin-specific protease, UBP43, cloned from leukemia fusion protein AML1-eto-expressing mice, functions in hematopoietic cell differentiation. Mol Cell Biol 1999; 19: 3029-3038.
20. Chen CY, Pajak L, Tamburlin J, Bofinger D, Koury ST: The effect of proteasome inhibitors on mammalian erythroid terminal differentiation. Exp Hematol 2002; 30: 634-639.
21. Marteijn JA, Jansen JH, van der Reijden BA: Ubiquitylation in normal and malignant hematopoiesis: novel therapeutic targets. Leukemia 2006; 20: 1511-1518.
22. Richardson PG, Sonneveld P, Schuster MW, Irwin D, Stadtmauer EA, Facon T, Harousseau JL, Ben-Yehuda D, Lonial S, Goldschmidt H, Reece D, San-Miguel JF, Blade J, Boccadoro M, Cavenagh J, Dalton WS, Boral AL, Esseltine DL, Porter JB, Schenkein D, Anderson KC: Bortezomib or high-dose dexamethasone for relapsed multiple myeloma. N Engl J Med 2005; 352: 2487-2498. (Pubitemid 41007864)